IL17A and Graves disease: One systematic review reported that Jia-Wei-Xiao-Yao-San, commonly prescribed to treat Graves’ disease, exerted anti-inflammatory effects that diminished the apoptosis of thyroid follicular cells through the IL-17 signaling pathway [19].